AAP
SNY icon

Arax Advisory Partners’s Sanofi SNY Stock Holding History

Arax Advisory Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
25,469
+15,210
+148% +$680K 0.01% 1165
2026
Q1 		$480K Sell
10,259
-11,317
-52% -$528K 0.01% 672
2025
Q4 		$1.04M Buy
21,576
+1,730
+9% +$85.8K 0.03% 375
2025
Q3 		$937K Buy
19,846
+14,598
+278% +$705K 0.01% 662
2025
Q2 		$254K Sell
5,248
-844
-14% -$43.1K 0.01% 575
2025
Q1 		$338K Buy
6,092
+5,607
+1,156% +$304K 0.02% 393
2024
Q4 		$23.4K Sell
485
-231
-32% -$11.7K ﹤0.01% 1149
2024
Q3 		$41.3K Buy
716
+13
+2% +$702 ﹤0.01% 792
2024
Q2 		$34.1K Sell
703
-22
-3% -$1.06K ﹤0.01% 791
2024
Q1 		$35.2K Buy
725
+154
+27% +$7.52K ﹤0.01% 561
2023
Q4 		$28.4K Sell
571
-47
-8% -$2.3K ﹤0.01% 597
2023
Q3 		$33.1K Buy
618
+26
+4% +$1.39K ﹤0.01% 514
2023
Q2 		$31.9K Buy
592
+129
+28% +$6.94K ﹤0.01% 521
2023
Q1 		$25.2K Buy
463
+344
+289% +$16.7K ﹤0.01% 548
2022
Q4 		$5.76K Hold
119
– – ﹤0.01% 754
2022
Q3 		$5K Sell
119
-55
-32% -$2.45K ﹤0.01% 821
2022
Q2 		$9K Buy
174
+87
+100% +$4.62K ﹤0.01% 672
2022
Q1 		$4K Buy
87
+54
+164% +$2.79K ﹤0.01% 845
2021
Q4 		$2K Buy
+33
New +$1.63K ﹤0.01% 929
2021
Q3 		– Sell
-45
Closed -$2K – 1067
2021
Q2 		$2K Buy
+45
New +$2.35K ﹤0.01% 861
2020
Q4 		$41K Buy
836
+54
+7% +$2.66K 0.01% 437
2020
Q3 		$39K Sell
782
-42
-5% -$2.16K 0.01% 416
2020
Q2 		$42K Buy
824
+264
+47% +$12.8K 0.01% 391
2020
Q1 		$24K Buy
560
+143
+34% +$6.84K 0.01% 441
2019
Q4 		$21K Buy
+417
New +$19.5K 0.01% 415
2018
Q4 		$8K Hold
181
– – ﹤0.01% 457
2018
Q3 		$8K Buy
+181
New +$7.73K ﹤0.01% 493

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Arax Advisory Partners's SNY Position: Q2 2026 in Review

Arax Advisory Partners increased its Sanofi (SNY) stake by 148% in Q2 2026, buying an estimated $680K and bringing the position to 25,469 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #1165.

Arax Advisory Partners first reported a position in SNY in Q3 2018 and has held it in 27 quarters since. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Arax Advisory Partners held 25,469 shares of Sanofi worth $1.09M as of Q2 2026.
  • Arax Advisory Partners bought 15,210 Sanofi shares in Q2 2026, an estimated $680K.
  • Sanofi made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1165 holding.
  • Arax Advisory Partners first reported a position in Sanofi in Q3 2018 and has held it in 27 quarters since.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.